Table 2.
Biomarker | OR | X2 | 95% Confidence intervals | p | |
---|---|---|---|---|---|
Lower | Upper | ||||
PRE-TREATMENT | |||||
Tie2 | 2.651 | 11.672 | 1.325 | 5.303 | 0.006* |
PlGF | 0.344 | 0.383 | 0.011 | 10.386 | 0.547 |
VEGF | 1.365 | 0.216 | 0.366 | 5.089 | 0.652 |
VEGFC | 0.159 | 3.327 | 0.018 | 1.362 | 0.045* |
VEGFD | 0.118 | 3.738 | 0.011 | 1.220 | 0.087 |
bFGF | 0.288 | 2.949 | 0.124 | 1.209 | 0.084 |
sFlt1 | 0.377 | 0.273 | 0.009 | 15.098 | 0.627 |
BDNF | 0.025 | 11.921 | 0.001 | 0.500 | 0.012* |
POST-TREATMENT | |||||
Tie2 | 3.008 | 11.823 | 1.308 | 6.917 | 0.010* |
PlGF | 1.326 | 1.156 | 0.781 | 2.251 | 0.295 |
VEGF | 0.818 | 0.123 | 0.266 | 2.519 | 0.728 |
VEGFC | 0.083 | 7.853 | 0.008 | 0.839 | 0.007* |
VEGFD | 0.128 | 2.064 | 0.007 | 2.475 | 0.196 |
bFGF | 0.681 | 0.413 | 0.209 | 2.220 | 0.572 |
sFlt1 | 0.201 | 0.809 | 0.006 | 7.007 | 0.354 |
BDNF | 0.028 | 5.557 | 0.001 | 1.338 | 0.126 |
Different between patients and controls, at both p < 0.05 and q < 0.1.
OR, odds ratio; x2, Chi-square.
Other factors did not differ between patient (n = 36) and control groups (n = 36) following FDR control for multiple comparisons.